Clinical Research Facility in Miami, fl
Built for Research Excellence
Clinical Pharmacology of Miami’s state-of-the-art research facility was purpose-built to support the successful execution of Phase I-IV clinical trials. Opened in 2025, our 75,000-square-foot facility combines modern infrastructure, advanced technology, and experienced research professionals to meet the unique needs of sponsors, CROs, and study participants.
Our campus features more than 150 research beds and is designed to support a wide range of clinical research programs, from first-in-human studies to complex specialty protocols. With dedicated spaces for participant care, sample processing, monitoring, and data collection, CPMI delivers the flexibility, quality, and operational excellence sponsors expect.
Backed by the ERG Network, CPMI provides the experience, scalability, and commitment needed to help bring new therapies to patients safely and efficiently.
Quality, Security & Reliability
Clinical Pharmacology of Miami is committed to maintaining the highest standards of quality, safety, and operational excellence. Our facility utilizes advanced environmental monitoring systems to continuously track the storage conditions of study medications and laboratory samples, helping ensure their quality and integrity.
The facility is equipped with secure, controlled access and 24/7 security monitoring to help protect participants, staff, research materials, and study data.
To support uninterrupted study operations, CPMI is backed by an emergency power generation system capable of maintaining critical facility functions during power outages, including medication storage, laboratory equipment, and security systems. This infrastructure helps ensure studies can continue safely and reliably, even in unexpected circumstances.
Since its inception, Clinical Pharmacology of Miami, has participated in approximately 1800 clinical studies of the safety and efficacy and mechanisms of action of Phase I, II and III drugs as well as bioavailability and pharmacokinetic studies in normal subjects as well as in special populations. Numerous clinical studies have been successfully audited by sponsoring institutions and by the Food and Drug Administration.
Virtually all studies have been conducted under auspices of active IND applications and approximately 60 successful NDA’s have contained data generated by these studies, including:
- Acrovastine
- Aalendronate
- Amiloride
- Amrinone
- Arbutamine
- Atenolol
- Benzazepril
- Candesartan Cilexetil
- Carteolol
- Caspofungin
- Ciprofloxacin
- Dofetilide
- Enalapril
- Encainide
- Eplerenone
- Recombinant Erythropoietin
- Etodolac
- Famotidine
- Felodipine
- Finasteride
- Flecanide
- Fosinopril
- Galantamine
- Grepafloxacin
- Indapamide
- Irbesartan
- Leucovorin
- Lisinopril
- Losartan
- Meropenem
- Milrinone
- Moexepril
- Montelukast
- Nefazodone
- Nimodipine
- Nisoldipine
- Nitroprusside
- Nizatidine
- Oxaprozin
- Penbutalol
- Pinacidil
- Piperacillin
- Piroxicam
- Prazosin
- Ramipril
- 13-Cis Retinoic Acid
- Rofecoxib
- Sinemet CR
- Sirolimus
- Sitagliptin
- Sulindac
- Sulindac
- Tegaserod
- Timolol
- Terazocin
- Tocanide
- Trandolapril
- Valsartan
- Venlafaxin
- Zafirlukast
- Zolmitriptan
- Zolpidem
- Acrovastine
- Aalendronate
- Amiloride
- Amrinone
- Arbutamine
- Atenolol
- Benzazepril
- Candesartan cilexetil
- Carteolol
- Caspofungin
- Ciprofloxacin
- Dofetilide
- Enalapril
- Encainide
- Eplerenone
- Recombinant erythropoietin
- Etodolac
- Famotidine
- Felodipine
- Finasteride
- Flecanide
- Fosinopril
- Galantamine
- Grepafloxacin
- Indapamide
- Irbesartan
- Leucovorin
- Lisinopril
- Losartan
- Meropenem
- Milrinone
- Moexepril
- Montelukast
- Nefazodone
- Nimodipine
- Nisoldipine
- Nitroprusside
- Nizatidine
- Oxaprozin
- Penbutalol
- Pinacidil
- Piperacillin
- Piroxicam
- Prazosin
- Ramipril
- 13-cis retinoic acid
- Rofecoxib
- Sinemet CR
- Sirolimus
- Sitagliptin
- Sulindac
- Tegaserod
- Timolol
- Terazocin
- Tocanide
- Trandolapril
- Valsartan
- Venlafaxin
- Zafirlukast
- Zolmitriptan
- Zolpidem
State-of-the-Art Clinical Research Facility in Miami, FL
Designed with both participants and sponsors in mind, our modern research facility provides a safe, comfortable, and professionally managed environment for clinical research. From screening through study completion, our experienced team supports every aspect of the participant experience.
- Dedicated screening, examination, and outpatient visit areas
- Secure laboratory for sample processing and storage
- Temperature-monitored pharmacy and specimen storage systems
- More than 120 research beds, including private accommodations
- Specialized research areas for PK and cardiac monitoring studies
- Comfortable participant amenities, including recreation areas and internet access
- Onsite parking and transportation support through Uber Health
- 24/7 clinical staff coverage and security monitoring
- Secure, controlled facility access
- Emergency backup power systems to support uninterrupted operations
- Conference rooms, monitoring space, and onsite study support teams
- Fully handicap-accessible facility
At CPMI, we’ve created a research environment that prioritizes participant comfort, safety, and quality while supporting the successful conduct of clinical studies.
- Screening Department / Interview / Exam Rooms / Prescreening lab & more
- Out-patient department
- Secure and monitored PK sample processing laboratory
- Secure temperature alarm monitored -20 and -80C freezers
- Secure alarm monitored pharmacy department
- Secure and monitored CRF / Record rooms
- Secure Entryways
- Standby Generator
- 120 clinical research beds
- 3 large PK rooms
- 6 private research rooms (2 plus beds each)
- Recreational activities planned for volunteers and access to a pool table
- Supervised Internet access areas for subjects
- Entire facility monitored by clinical staff, onsite 24 hours a day 7 days a week
- Security Video Monitor Recording 24 hours a day, 7 days a week
- Conference rooms
- Multiple monitor rooms with Internet, copier & phone
- Study coordinator / offices
- Ultrasounds contracted in for Women’s Health studies
- Data entry / regulatory affairs department
- Entire facility handicap accessible
- Onsite parking and use of Uber Health for subjects
- QTc Clinical trial ECG monitored research areas equipped with individual telemetry units